Archive for the ‘National Standards for Cognitive Testing’ Category

Cognitive Screening & Testing Report Released

19th June 2013 by Christian Elliott Comments Off

Computerized Cognitive Assessment Products – Neurocognitive Screening for ADHD, Memory Loss, Alzheimer’s, Dementia, Traumatic Brain Injury Since our last report in 2011, the market for computerized cognitive assessment, screening and testing has continued to expand. Key drivers for this market and growing technology product base include: An Aging Global Population: 500 million people in the […]

    Early Detection Tests for Alzheimer’s Disease: Introduction

    7th January 2013 by Christian Elliott Comments Off

    Rising Dementia Rates are a Global Health Trend A positive aspect of rising living standards in most of the world has been a significant improvement in worldwide average life expectancies, increasing from 52 years in 1960 to 69 years in 2009. Regional differences are even more striking — the average life expectancy for a person […]

      Detecting Alzheimer’s Disease 20 Years Before Symptoms Appear

      17th July 2012 by Christian Elliott Comments Off

      A research team at Washington University School of Medicine just published the results of a study that looked at a number of cognitive changes and biomarkers that can be used to predict the risk of Alzheimer’s Disease long before symptoms appear – in some cases up to 20 years before symptom onset. The study, published […]

        New Progress on a Blood Test for Alzheimer’s Disease

        2nd July 2012 by Christian Elliott Comments Off

        The PLoS ONE science journal published an interesting study performed by the Brain and Aging Research Program at the University of New South Wales in Sydney, Australia. The study sampled apolipoprotein levels in blood samples from over 600 older adults participating in the ongoing Sydney Memory and Aging Study. Apolipoproteins are proteins that transport cholesterol […]

          The Pros and Cons of Amyvid for Amyloid Beta Imaging

          25th June 2012 by Christian Elliott Comments Off

          A topic that received a lot of attention at the University of California San Diego School of Medicine update on Alzheimer’s research was the use of Eli Lilly’s Amyvid for detection of amyloid beta deposits in the brain, one of the physical signatures of Alzheimer’s Disease. Dr. Gil Rabinovici, MD, a physician and researcher at […]